Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.54 |
| ▸ | RECQL | P46063 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 2/20 | 0.43 |
| ▸ | BCR | P11274 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM6 | O15303 | 1/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30783383 | 1.00 | LMNA (0.54) | LMNARECQLALDH1A1MEN1KMT2A | |
| SCHEMBL29902892 | 0.87 | ATM (0.51) | LMNARECQLALDH1A1MEN1KMT2A | |
| SCHEMBL28847424 | 0.87 | ATM (0.51) | LMNARECQLALDH1A1MEN1KMT2A | |
| SCHEMBL2656422 | 0.85 | LMNA (0.53) | LMNARECQLALDH1A1MEN1KMT2A | |
| SCHEMBL2648717 | 0.85 | LMNA (0.53) | LMNARECQLALDH1A1MEN1KMT2A | |
| SCHEMBL4684043 | 0.85 | CASP6 (0.49) | LMNAALDH1A1MAPTHTTCA2 | |
| SCHEMBL5362455 | 0.84 | LMNA (0.52) | LMNARECQLALDH1A1MEN1KMT2A | |
| SCHEMBL2339087 | 0.84 | LMNA (0.55) | LMNARECQLALDH1A1MEN1KMT2A | |
| SCHEMBL7252708 | 0.84 | LMNA (0.52) | LMNARECQLALDH1A1MEN1KMT2A | |
| SCHEMBL2742575 | 0.82 | MAPT (0.58) | LMNAALDH1A1MAPTSMN1; SMN2CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11969425-B2 | Inhibitor of indoleamine-2,3-dioxygenase (IDO) | INVENTISBIO LLC (US) | 2024-04-30 | — | — | US | disclosed |
| CN-113896685-B | Indoleamine-2, 3-dioxygenase (IDO) inhibitors | 益方生物科技(上海)股份有限公司 | 2024-02-06 | — | — | CN | disclosed |
| US-20230338373-A1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | INVENTISBIO LLC | 2023-10-26 | — | — | US | disclosed |
| EP-3414224-B1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | INVENTISBIO LLC (US) | 2022-03-23 | — | — | EP | disclosed |
| US-20220054486-A1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | INVENTISBIO LLC (US) | 2022-02-24 | — | — | US | disclosed |
| CN-113896685-A | Indoleamine-2, 3-dioxygenase (IDO) inhibitors | 益方生物科技(上海)股份有限公司 | 2022-01-07 | — | — | CN | disclosed |
| US-10980807-B2 | Inhibitor of indoleamine-2,3-dioxygenase (IDO) | INVENTISBIO LLC (US) | 2021-04-20 | — | — | US | disclosed |
| US-20200046697-A1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | INVENTISBIO LLC | 2020-02-13 | — | — | US | disclosed |
| EP-3414224-A1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | Inventisbio Inc. (KY) | 2018-12-19 | — | — | EP | disclosed |
| WO-2017139414-A1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | INVENTISBIO INC. (KY) | 2017-08-17 | — | — | WO | disclosed |
| US-7686850-B2 | Nitrosulfide dyes | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-03-30 | — | — | US | disclosed |
| US-20090130045-A1 | Nitrosulfide dyes | CIBA SPECIALTY CHEMICALS CORP. | 2009-05-21 | — | — | US | disclosed |
| US-20090100610-A1 | Mixture of Sulfide Dyes | CIBA CORPORATION | 2009-04-23 | — | — | US | disclosed |
| CN-101326246-A | Mixture of sulfide dyes | CIBA SC HOLDING AG (CH) | 2008-12-17 | — | — | CN | disclosed |
| EP-1937780-A2 | MIXTURE OF SULFIDE DYES | Ciba Holding Inc. (CH) | 2008-07-02 | — | — | EP | disclosed |
| CN-101203573-A | Nitrosulfide dyes | CIBA SC HOLDING AG (CH) | 2008-06-18 | — | — | CN | disclosed |
| EP-1893697-A2 | NITROSULFIDE DYES | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006136617-A2 | MIXTURE OF SULFIDE DYES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-12-28 | — | — | WO | disclosed |
| WO-2006136518-A2 | NITROSULFIDE DYES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-12-28 | — | — | WO | disclosed |
| WO-2003099242-A1 | COSMETIC AGENTS CONTAINING PROTEIN DISULFIDE ISOMERASE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-12-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230338373-A1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | IDO1, IDO2, INMT | LMNA 4749/4885RECQL 1256/4885ALDH1A1 801/4885 |
| US-20090100610-A1 | Mixture of Sulfide Dyes | KRT18, TST, ARSA | LMNA 2959/4885RECQL 4000/4885ALDH1A1 360/4885 |
| US-11969425-B2 | Inhibitor of indoleamine-2,3-dioxygenase (IDO) | IDO1, IDO2, INMT | LMNA 4749/4885RECQL 1256/4885ALDH1A1 801/4885 |
| US-20220054486-A1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | IDO1, IDO2, INMT | LMNA 4749/4885RECQL 1256/4885ALDH1A1 801/4885 |
| US-20200046697-A1 | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | IDO1, IDO2, INMT | LMNA 4749/4885RECQL 1256/4885ALDH1A1 801/4885 |
| US-20090130045-A1 | Nitrosulfide dyes | C5, NOX5, C3AR1 | LMNA 1304/4885RECQL 711/4885ALDH1A1 881/4885 |
| US-10980807-B2 | Inhibitor of indoleamine-2,3-dioxygenase (IDO) | IDO1, IDO2, INMT | LMNA 4749/4885RECQL 1256/4885ALDH1A1 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.